RANI
Rani Therapeutics Holdings Inc
NASDAQ: RANI · HEALTHCARE · BIOTECHNOLOGY
$0.94
+5.87% today
Updated 2026-05-01
Market cap
$108.42M
P/E ratio
—
P/S ratio
66.39x
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$0 – $4
Volume
1.1M
Rani Therapeutics Holdings Inc (RANI) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+17.7%
Last 4 quarters
Revenue YoY growth
+42.1%
Most recent quarter
EPS YoY growth
+74.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-8.7%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-19.2%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-25 | $-0.07 | -47.4% | $1.06 | $1.08 | +1.9% |
| 2025-11-06 | $-0.12 | +29.4% | $2.50 | $2.02 | -19.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.05 | $-0.07 | -47.4% | $1.46M | +42.1% |
| 2025-09-30 | $-0.17 | $-0.12 | +29.4% | — | — |
| 2025-06-30 | $-0.29 | $-0.18 | +37.9% | — | — |
| 2025-03-31 | $-0.24 | $-0.27 | -14.1% | $172000.00 | — |
| 2024-12-31 | $-0.26 | $-0.27 | -3.8% | $1.03M | -62.6% |
| 2024-09-30 | $-0.26 | $-0.24 | +7.7% | — | — |
| 2024-06-30 | $-0.32 | $-0.26 | +18.8% | — | — |
| 2024-03-31 | $-0.20 | $-0.29 | -45.0% | — | — |
| 2023-12-31 | $-0.31 | $-0.27 | +12.9% | $2.75M | — |
| 2023-09-30 | $-0.37 | $-0.36 | +2.7% | — | — |
| 2023-06-30 | $-0.40 | $-0.37 | +7.5% | — | — |
Frequently asked questions
Has Rani Therapeutics Holdings Inc beaten earnings estimates?
Rani Therapeutics Holdings Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +17.7% over the last 3 quarters.
How does RANI stock react to earnings?
RANI stock has moved an average of -8.7% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Rani Therapeutics Holdings Inc's revenue growth rate?
Rani Therapeutics Holdings Inc reported year-over-year revenue growth of +42.1% in its most recent quarter, with EPS growing +74.1% year-over-year.